When the angiogenic and vasodilatation effects of apelin are considered, increasing apelin circulating levels in preeclampsia patients may affect mother and fetus outcomes positively by improving the maternal adaptation to pregnancy [28]. The gene discussed is APLN; the disease is preeclampsia.